literacy < literature < literatures

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]

Ident.	Authors (with country if any)	Title
000048 (2020)	Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]	Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000063 (2020)	Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Tsutomu Takeuchi [Japon]	Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review.
000081 (2020)	Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]	The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000091 (2020)	Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France]	The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.
000134 (2020)	Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]	Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000141 (2020)	Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]	Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000157 (2020)	Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]	Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000162 (2020)	Alexandre Sepriano [Oman] ; Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas]	Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
000177 (2020)	Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. Sharaiha	SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000192 (2020)	Igor Kos [Allemagne] ; Stephan Stilgenbauer [Allemagne] ; Moritz Bewarder [Allemagne]	Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature.
000205 (2020)	Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis]	Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
000206 (2020)	Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos	Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000214 (2020)	Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]	Progression of fibrosing interstitial lung disease
000225 (2020)	Ali Rismanbaf [Iran]	Potential Treatments for COVID-19; a Narrative Literature Review
000235 (2020)	Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis]	Pharmacotherapy in COVID-19; A narrative review for emergency providers
000259 (2020)	Sara Pagani [Royaume-Uni] ; Mattia Bellan [Italie] ; Daniele Mauro [Royaume-Uni] ; Luigi Mario Castello [Italie] ; Gian Carlo Avanzi [Italie] ; Myles J. Lewis [Royaume-Uni] ; Pier Paolo Sainaghi [Italie] ; Costantino Pitzalis [Royaume-Uni] ; Alessandra Nerviani [Royaume-Uni]	New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
000266 (2020)	Jessica Vandenhaute [Belgique] ; Carine H. Wouters [Belgique] ; Patrick Matthys [Belgique]	Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
000267 (2020)	Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea Antinori	National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000268 (2020)	Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]	NK Cell-Based Immune Checkpoint Inhibition
000272 (2020)	Jinwen Lin ; Shiping Yu ; Rending Wang ; Jianghua Chen	Multicentric Castleman’s disease in a renal allograft recipient: a case report and literature review
000273 (2020)	Zheng Wang [États-Unis] ; Yicheng Zhao [États-Unis] ; Zhiqiang An [États-Unis] ; Wenliang Li [États-Unis]	Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "literature" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "literature" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    literature
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021